Altered NMDA glutamate receptor antagonist response in recovering ethanol-dependent patients. - Wikidata - awgldk - TriplyDB

Altered NMDA glutamate receptor antagonist response in recovering ethanol-dependent patients.

Altered NMDA glutamate receptor antagonist response in recovering ethanol-dependent patients.

http://www.wikidata.org/entity/Q44531004

about

Treatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as Therapy Glial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity?Hangover and risk for alcohol use disorders: existing evidence and potential mechanisms Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder Contributions of magnetic resonance spectroscopy to understanding development: potential applications in the study of adolescent alcohol use and abuse The Subjective Response to Nitrous Oxide is a Potential Pharmaco-Endophenotype for Alcohol Use Disorder: A Preliminary Study with Heavy Drinkers Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.NR2B-deficient mice are more sensitive to the locomotor stimulant and depressant effects of ethanol Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics Characterization of the interactive effects of glycine and D-cycloserine in men: further evidence for enhanced NMDA receptor function associated with human alcohol dependence.N-methyl-D-aspartate receptor antagonism has differential effects on alcohol craving and drinking in heavy drinkers Repeated ketamine administration alters N-methyl-D-aspartic acid receptor subunit gene expression: implication of genetic vulnerability for ketamine abuse and ketamine psychosis in humans.Ethanol-like effects of thiopental and ketamine in healthy humans.Aggression and increased glutamate in the mPFC during withdrawal from intermittent alcohol in outbred mice Alcohol and violence: neuropeptidergic modulation of monoamine systems.Family history of alcohol dependence and antidepressant response to an N-methyl-D-aspartate antagonist in bipolar depression The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia.Biologic Commonalities between Mental Illness and Addiction.Psychiatric safety of ketamine in psychopharmacology research.The neurobiology of schizotypy: fronto-striatal prediction error signal correlates with delusion-like beliefs in healthy people.Neural correlates of change in major depressive disorder anhedonia following open-label ketamine.Glutamate plasticity woven through the progression to alcohol use disorder: a multi-circuit perspective.Evaluation of adjunctive ketamine to benzodiazepines for management of alcohol withdrawal syndrome.Metaplastic effects of subanesthetic ketamine on CA1 hippocampal function.Two cases of delayed-onset suicidal ideation, dysphoria and anxiety after ketamine infusion in patients with obsessive-compulsive disorder and a history of major depressive disorder.Potentiation of low dose ketamine effects by naltrexone: potential implications for the pharmacotherapy of alcoholism.Absence of significant interactive effects of high-dose D-cycloserine and ethanol in healthy human subjects: preliminary insights into ethanol actions at the glycine B site of NMDA glutamate receptors.Gelatin "shots" as a new method for alcohol administration in a laboratory setting.Non-Competitive NMDA Receptor Antagonist Hemantane Reduces Ethanol Consumption in Long-Term Alcohol Experienced Rats.Antiglutamatergic strategies for ethanol detoxification: comparison with placebo and diazepam.The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects Ketamine’s Mechanism of Rapid Antidepressant Activity: Evidence Gleaned from Clinical Studies

P2860

Q26773084-9A7C1564-F4D7-4EF3-91EC-C77A59D9A4AF Q26829556-FBF7A8CA-E579-47F6-9450-B02AA9F16D37 Q28290604-544C4819-6A65-47B6-BA5F-E64C9AD9EBA1 Q30711088-339EE911-697F-48EA-B243-97CCEA15FA78 Q30775959-DDEF407F-D8EE-487E-83E2-A1D149D5D9DB Q33614487-39EB30D4-FDD9-4737-A31E-3E249FA60E1A Q33874459-808C2AF4-C090-48A0-BFA6-01379DF7F706 Q34162623-C880DE0C-5169-418C-9EE4-46D6C4239691 Q34444632-044F4BB9-C29E-40CD-8CAD-714310CB2D7F Q34661868-BFFA2EB2-9D4D-497B-A89B-EBC983B1EB1A Q35091293-61AB5837-0E6D-438B-9CB4-07ADCD3CD211 Q35747469-DB4BCB1B-D2EC-49F7-802D-DD46FB973E71 Q35794858-726A7E4E-910D-4469-8263-55D8577EB1F5 Q35889443-17A93B2D-BD7B-47DD-ABDD-E70AB1FA17C2 Q36042637-7A969CF7-C7D0-4CB0-93B7-4235E18AF24E Q36417179-76EA3AA8-FC19-430E-99A3-C3671FF9ADAA Q36696097-03D42A3B-FCBD-40AB-B0D8-D98F67545C96 Q36756858-13E29212-EF94-4D87-80CC-524F174C7F49 Q36801464-6678D735-F79C-4459-B1DA-86DE84756C91 Q36959377-020E3C18-DD66-43D2-92B8-D044C1CC2582 Q37424327-C38AF6C0-BD71-42B4-8908-9044A8F666C5 Q37720496-625154E7-D600-4AB8-BC73-56FCFB660D0F Q38261134-FEA3E863-57F3-4B37-B7C9-DC90D19C2FC5 Q41926184-1F4293B2-C075-47ED-A727-73C702E16D0B Q42599339-0DB07F90-71DB-452B-878D-0BA851729286 Q46881184-B8BDEB3E-BB90-4C33-8199-5BC8CC415960 Q46889511-1AC4D8E5-427C-479F-BE1A-01A17F320B87 Q46961762-41D8A730-1E12-4FE5-9072-EF8DF038E680 Q47304998-D8A39561-46AB-47AC-9144-77B4390D0BEB Q48613264-1A5A758B-7D98-4EC9-B291-4D00F9BD887C Q58213859-1DAB3ED6-3AAB-4F12-BFBB-D59B81C578CA Q58213893-ED483056-DE28-438F-B93C-713A64A78D24

P2860

Altered NMDA glutamate receptor antagonist response in recovering ethanol-dependent patients.

http://www.wikidata.org/entity/Q44531004

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Altered NMDA glutamate recepto ...... ng ethanol-dependent patients.

@en

Altered NMDA glutamate recepto ...... ng ethanol-dependent patients.

@nl

type

label

Altered NMDA glutamate recepto ...... ng ethanol-dependent patients.

@en

Altered NMDA glutamate recepto ...... ng ethanol-dependent patients.

@nl

prefLabel

Altered NMDA glutamate recepto ...... ng ethanol-dependent patients.

@en

Altered NMDA glutamate recepto ...... ng ethanol-dependent patients.

@nl

P1433

Q44531004-2A6AA3F5-C8B3-48C1-9521-0A64E390E3CA

P1476

Q44531004-4BDBBE00-56E0-4B92-B287-26F25D03CD2C

P2093

Q44531004-0B7FB59A-97F7-484E-99CA-19186EBEC8BB

Q44531004-2E347D74-382E-4088-A027-5EDBCDE8A889

Q44531004-5A649D04-E11B-40DE-AB96-AA1817887AC7

Q44531004-7226C177-705E-47A3-9AD0-006D5C9110AB

Q44531004-972FF07B-A745-47A1-9FEF-DDFB9B3C77A0

Q44531004-9F12729E-A81D-4F37-82AE-BF4A3D9CAB0B

Q44531004-DC8CA80F-35D7-401F-B35B-D949EC5D9342

Q44531004-E96A6BFB-CF76-441F-94E9-EEC644FCEADA

Q44531004-FAF091C5-39BE-4544-895B-E2F48021682B

P2860

Q44531004-12E7D39E-E732-40E7-8E88-4B1AF2628783

Q44531004-2B342C67-BB69-40C0-9007-205584C4A2FA

Q44531004-39541983-0203-41E8-AF0A-7F13D584420C

Q44531004-415EB9BC-B588-48F3-9926-1553166A0EF0

Q44531004-43AFB8FB-2777-4FE6-A423-92C2E55FDA1A

Q44531004-4A940F43-7A9B-46B1-96AB-04E4DEBC3763

Q44531004-5028B23B-E765-45F8-984C-E1DCA97D551C

Q44531004-5BFC9E1A-01BA-4C07-B46E-02D38A92831C

Q44531004-717E86A3-87F7-4FEF-AB57-E8E3773E9310

Q44531004-76F39AC5-DA94-4153-9BA4-615AF3C68462

P2888

Q44531004-A91F6C06-E765-4223-A89B-4BFD4FD9EEF5

P304

Q44531004-9512FC7D-BFBB-48F4-943C-9F45C461A925

P31

Q44531004-E1391F2A-C121-4BB4-8AFD-E992F4636B29

P356

Q44531004-C488A9DE-E712-4875-9E54-67D8B9A0A1E3

P407

Q44531004-BBAB6ECD-DAA7-42B8-9ADF-6E94FC555BDC

P433

Q44531004-E1B5DC21-8ACE-49D2-89EF-BCEA2396BC16

P478

Q44531004-3976803D-A18D-42E3-B6FE-EA941097E362

P577

Q44531004-26159704-FC15-47A8-98BD-B61900A6AEC7

P5875

Q44531004-C9FC955D-A858-4133-B327-ECA74C3A3E08

P698

Q44531004-113033FB-CEE3-435D-8434-4C28199736AD

P921

Q44531004-AF23F63F-95E8-4CD6-BF5C-0B8B655A16A8

P356

P1433

Neuropsychopharmacology

P1476

Altered NMDA glutamate recepto ...... ng ethanol-dependent patients.

@en

P2093

D Cyril D'Souza

http://www.w3.org/2001/XMLSchema#string

Dennis S Charney

http://www.w3.org/2001/XMLSchema#string

Diana Limoncelli

http://www.w3.org/2001/XMLSchema#string

Elizabeth Webb

http://www.w3.org/2001/XMLSchema#string

Ismene L Petrakis

http://www.w3.org/2001/XMLSchema#string

John H Krystal

http://www.w3.org/2001/XMLSchema#string

Louis Trevisan

http://www.w3.org/2001/XMLSchema#string

Nashaat N Boutros

http://www.w3.org/2001/XMLSchema#string

Ralitza Gueorgueva

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

The role of glutamatergic neurotransmission in the pathophysiology of alcoholism

Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

PHARMACOLOGIC EFFECTS OF CI-581, A NEW DISSOCIATIVE ANESTHETIC, IN MAN.

The analysis of longitudinal polytomous data: generalized estimating equations and connections with weighted least squares.

Ethanol and the NMDA receptor.

The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description.

Brain regional specificity and time-course of changes in the NMDA receptor-ionophore complex during ethanol withdrawal.

Platelet MAO activity as a biological marker in subgroups of alcoholism.

P2888

P304

2020-2028

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.NPP.1300252

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2003-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10637502

http://www.w3.org/2001/XMLSchema#string

P698

12888778

http://www.w3.org/2001/XMLSchema#string

P921